AR050812A1 - Una solucion farmacologica caracterizada porque comprende dmso(dimetilsulfoxido), oxigeno y aceites vegetales y usos en la fabricacion de medicamentos - Google Patents

Una solucion farmacologica caracterizada porque comprende dmso(dimetilsulfoxido), oxigeno y aceites vegetales y usos en la fabricacion de medicamentos

Info

Publication number
AR050812A1
AR050812A1 ARP010102636A ARP010102636A AR050812A1 AR 050812 A1 AR050812 A1 AR 050812A1 AR P010102636 A ARP010102636 A AR P010102636A AR P010102636 A ARP010102636 A AR P010102636A AR 050812 A1 AR050812 A1 AR 050812A1
Authority
AR
Argentina
Prior art keywords
vegetable oils
oxygen
pharmacological solution
dimetilsulfoxide
medicines
Prior art date
Application number
ARP010102636A
Other languages
English (en)
Original Assignee
Stenti Haydee Alba
Pirillo Claudia Fernanda
Pastoriza Jose Maria
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stenti Haydee Alba, Pirillo Claudia Fernanda, Pastoriza Jose Maria filed Critical Stenti Haydee Alba
Priority to ARP010102636A priority Critical patent/AR050812A1/es
Priority to US10/162,284 priority patent/US7270834B2/en
Publication of AR050812A1 publication Critical patent/AR050812A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Es una solucion farmacologica compuesta por dimetilsulfoxido, oxígeno ozonizado y aceites vegetales. La solucion farmacologica es para uso en medicina humana y veterinaria. Su aplicacion es externa, de forma topica. La composicion farmacéutica es util para tratar artritis, artrosis, dolores lumbares, dolores musculares, dolores dorsales, tendosinovitis, flebitis, bursitis, hematomas, edemas subcutáneas; afecciones de origen articular, sinovial, tendinoso y de la cápsula articular causados por entrenamiento deportivo en seres humanos y animales.
ARP010102636A 2001-06-01 2001-06-01 Una solucion farmacologica caracterizada porque comprende dmso(dimetilsulfoxido), oxigeno y aceites vegetales y usos en la fabricacion de medicamentos AR050812A1 (es)

Priority Applications (2)

Application Number Priority Date Filing Date Title
ARP010102636A AR050812A1 (es) 2001-06-01 2001-06-01 Una solucion farmacologica caracterizada porque comprende dmso(dimetilsulfoxido), oxigeno y aceites vegetales y usos en la fabricacion de medicamentos
US10/162,284 US7270834B2 (en) 2001-06-01 2002-06-03 Pharmaceutical composition comprising dimethylsulfoxide and ozone

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ARP010102636A AR050812A1 (es) 2001-06-01 2001-06-01 Una solucion farmacologica caracterizada porque comprende dmso(dimetilsulfoxido), oxigeno y aceites vegetales y usos en la fabricacion de medicamentos

Publications (1)

Publication Number Publication Date
AR050812A1 true AR050812A1 (es) 2006-11-29

Family

ID=37492497

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010102636A AR050812A1 (es) 2001-06-01 2001-06-01 Una solucion farmacologica caracterizada porque comprende dmso(dimetilsulfoxido), oxigeno y aceites vegetales y usos en la fabricacion de medicamentos

Country Status (2)

Country Link
US (1) US7270834B2 (es)
AR (1) AR050812A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7615030B2 (en) * 2003-10-06 2009-11-10 Active O, Llc Apparatus and method for administering a therapeutic agent into tissue
EP1937286B1 (en) 2005-09-12 2016-03-09 Abela Pharmaceuticals, Inc. Compositions comprising dimethyl sulfoxide (dmso)
WO2007033180A1 (en) 2005-09-12 2007-03-22 Abela Pharmaceuticals, Inc. Materials for facilitating administration of dimethyl sulfoxide (dmso) and related compounds
US8480797B2 (en) 2005-09-12 2013-07-09 Abela Pharmaceuticals, Inc. Activated carbon systems for facilitating use of dimethyl sulfoxide (DMSO) by removal of same, related compounds, or associated odors
WO2007033083A2 (en) 2005-09-12 2007-03-22 Abela Pharmaceuticals, Inc. Systems for removing dimethyl sulfoxide (dmso) or related compounds, or odors associated with same
BRPI0921494A2 (pt) 2008-11-03 2018-10-30 Prad Reasearch And Development Ltd método de planejamento de uma operação de amostragem para uma formação subterrãnea, método de contolar uma operação de amostragem de formação subterrânea, método de controlar uma operação de perfuração para uma formação subterrãnea, e método de realizar uma amostragem durante a operação de perfuração.
US9855212B2 (en) 2009-10-30 2018-01-02 Abela Pharmaceuticals, Inc. Dimethyl sulfoxide (DMSO) or DMSO and methylsulfonylmethane (MSM) formulations to treat infectious diseases
US20110319805A1 (en) * 2010-06-29 2011-12-29 Bryan Knicely Morris Topical composition for treating the skin
DE102012007239A1 (de) * 2012-04-10 2013-10-10 Wolfgang Winkelmann Pharmazeutische Zusammensetzung enthaltend eine mit Sauerstoff angereicherte ungesättigte Fettsäure und ein organisches Lösungsmittel
EP3305288B1 (en) * 2016-10-10 2020-04-22 Dubaiomics FZ-LLC Cromoglycate for increasing hoof growth in ungulates

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4932400A (en) * 1988-06-09 1990-06-12 James Persinger Method and apparatus for inhibiting shipping fever in livestock and improving digestibility of consumed feed
US6663874B2 (en) * 1998-11-02 2003-12-16 Victor Stevens Composition to alleviate pain and topical method of applying same

Also Published As

Publication number Publication date
US20020182263A1 (en) 2002-12-05
US7270834B2 (en) 2007-09-18

Similar Documents

Publication Publication Date Title
AR050812A1 (es) Una solucion farmacologica caracterizada porque comprende dmso(dimetilsulfoxido), oxigeno y aceites vegetales y usos en la fabricacion de medicamentos
GT200500235A (es) Conjugados de hormona del crecimiento humana y polietilenglicol ramificado con glicerol, proceso para su preparacion y metodos de uso de los mismos
CU22995A3 (es) Derivados de pirazolinas, su preparación y su aplicación como medicamentos
ES2159382T3 (es) Compuestos estilbenicos con grupo adamantilo, composiciones que los contienen y utilizaciones.
CL2008000825A1 (es) Compuestos heterociclicos derivados de quinolincarboxamidas utiles como antagonistas de p2x7; su metodo de preparacion; la composicion farmaceutica que lo contiene; el emtodo de preparacion de la composicion; y el uso de los mismos para preparar medicamentos utiles en artritis reumatoide.
GT200100036A (es) Derivados de eteres de pirazol como agentes antiinflamatorios / analgesicos.
AR045783A1 (es) Composición farmacéutica que comprende un antagonista del receptor p2x7 y una droga anti-inflamatoria no esteroide
CL2011000118A1 (es) Compuestos derivados de imidazo[1,2-a]pirimidina; procedimiento de preparacion; composicion farmaceutica; compuestos intermediarios; y uso como inhibidores de quinasa para tratar cancer, trastornos metabolicos, alegis, asmas, trombosis, retonipatias, psoriasis, artritis reumatoide, diabetes, degeneracion muscular.
CY1124710T1 (el) Κετυλιωμενα λιπαρα οξεα, συστημα για την παρασκευη αυτων και χρηση αυτων
DK1677806T3 (da) Sammensætninger til behandling af akut og overbelastningsforårsaget forstuvning og forstrækning ved anvendelse af hyaluronsyre
AR044350A1 (es) Manguito y parche analgesico microencapsulado de uso topico para el tratamiento del dolor
AR055107A1 (es) Furoato de n-{2-[((2s)-3-{[1-(4-clorobencil)piperidin-4-il]amino}-2-hidroxi-2-metilpropil)oxi]-4-hidroxifenil} acetamida,composiciones farmaceuticas que los contienen y usos para tratar afecciones o enfermedades donde actuan como moduladores del receptor de quimioquina 1(ccr1)
ES2281249B1 (es) Linimento analgesico antiinflamatorio.
TN2015000150A1 (en) Stable injectable composition containing diclofenac and thiocolchicoside
CR6693A (es) Pirazolo (4,3-e) diazepinas sustituidas novedosas, composiciones farmaceuticas que las contienen, su uso como productos medicinales y procesos para prepararlas
CR8584A (es) Piperazinas derivadas de urea para el tratamiento de la endometrosis
RU2012125066A (ru) Профилактическое средство и/или терапевтическое средство, и/или средство, подавляющее ухудшение при деформирующем артрите у человека
AR074521A1 (es) Asociacion de ingredientes activos que contienen un farmaco antiinflamatorio, no esteroideo y un derivado de colchicosido
BR112014017544A2 (pt) fitocomposição para o tratamento de dores relacionadas com doenças das articulações
ES2387109A1 (es) Pulverización farmacéutica
CA3026871A1 (en) A product comprising glucosamine for external application
TH134381A (th) สารรวมแบบใหม่ของส่วนผสมออกฤทธิ์ที่มียาต้านการอักเสบที่ไม่ใช่สเทอรอยด์ และ อนุพันธ์คอลคิโคไซด์
BG1273U1 (bg) Хранителна добавка
TH134381B (th) สารรวมแบบใหม่ของส่วนผสมออกฤทธิ์ที่มียาต้านการอักเสบที่ไม่ใช่สเทอรอยด์ และ อนุพันธ์คอลคิโคไซด์
CL2004000625A1 (es) Composicion farmaceutica que comprende tolterodina y cacao en polvo; su uso en la fabricacion de medicamento util para el tratamiento de vejiga hiperactiva.

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed, e.g., due to non-payment of fee